Literature DB >> 17605119

[Quality of life in German-speaking patients with spinal cord injuries and bladder dysfunctions. Validation of the German version of the Qualiveen questionnaire].

J Pannek1, R Märk, M Stöhrer, B Schurch.   

Abstract

BACKGROUND: Neurogenic bladder dysfunctions in patients with spinal cord lesions may cause severe limitations in the quality of life (QoL). For assessment of QoL, a validated questionnaire in French is available. The goal of the study was to validate the German version of the questionnaire.
METHODS: Translation and intercultural adaptation were achieved in cooperation with an institute for health system research. The resulting German version was filled in by 439 patients in 18 centers in Germany, Austria, and Switzerland. Data were analyzed regarding clinical and sociodemographic characteristics. Quality criteria of the items and scales were tested by a detailed scale analysis.
RESULTS: Of the patients 65.8% were paraplegic and 32.8% were tetraplegic. Internal consistency, reliability, and validity of the questionnaire were very good. Differential effects could be displayed in all clinical variables that were tested.
CONCLUSIONS: The Qualiveen questionnaire is now available as the first instrument in the German language for the evaluation of the influence of bladder dysfunction on QoL in patients with spinal cord lesions.

Entities:  

Mesh:

Year:  2007        PMID: 17605119     DOI: 10.1007/s00120-007-1425-3

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  20 in total

Review 1.  Spinal cord injury and quality of life measures: a review of instrument psychometric quality.

Authors:  P Hallin; M Sullivan; M Kreuter
Journal:  Spinal Cord       Date:  2000-09       Impact factor: 2.772

2.  Mechanisms underlying the recovery of urinary bladder function following spinal cord injury.

Authors:  W C de Groat; M Kawatani; T Hisamitsu; C L Cheng; C P Ma; K Thor; W Steers; J R Roppolo
Journal:  J Auton Nerv Syst       Date:  1990-07

3.  The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association.

Authors:  M J Barry; F J Fowler; M P O'Leary; R C Bruskewitz; H L Holtgrewe; W K Mebust; A T Cockett
Journal:  J Urol       Date:  1992-11       Impact factor: 7.450

4.  Major depression in female urinary incontinence.

Authors:  Simone N Vigod; Donna E Stewart
Journal:  Psychosomatics       Date:  2006 Mar-Apr       Impact factor: 2.386

5.  Anxiety and depression after spinal cord injury: a longitudinal analysis.

Authors:  P Kennedy; B A Rogers
Journal:  Arch Phys Med Rehabil       Date:  2000-07       Impact factor: 3.966

6.  Health-related quality of life of patients using clean intermittent catheterization for neurogenic bladder secondary to spinal cord injury.

Authors:  Seung-June Oh; Ja Hyeon Ku; Hwang Gyun Jeon; Hyung-Ik Shin; Nam-Jong Paik; Taiwoo Yoo
Journal:  Urology       Date:  2005-02       Impact factor: 2.649

7.  Quality of life in spinal cord injury patients with urinary difficulties. Development and validation of qualiveen.

Authors:  P Costa; B Perrouin-Verbe; A Colvez; J Didier; P Marquis; A Marrel; G Amarenco; B Espirac; A Leriche
Journal:  Eur Urol       Date:  2001-01       Impact factor: 20.096

8.  Quality of life and traumatic spinal cord injury.

Authors:  N Westgren; R Levi
Journal:  Arch Phys Med Rehabil       Date:  1998-11       Impact factor: 3.966

9.  Quality of life: how is it measured and defined?

Authors:  S Breslin
Journal:  Urol Int       Date:  1991       Impact factor: 2.089

10.  A 15-year follow-up of 406 consecutive spinal cord injuries.

Authors:  D R Webb; J M Fitzpatrick; J D O'Flynn
Journal:  Br J Urol       Date:  1984-12
View more
  2 in total

Review 1.  [Prerequisites for a convincing (neuro-)urology opinion : Importance of objectivity in the legal sense of full proof, occurring under duty of compliance of the surveyed person].

Authors:  M Zellner; W Schöps; O P Jungmann; R Böthig; T Kadhum; K Golka
Journal:  Urologe A       Date:  2018-07       Impact factor: 0.639

Review 2.  [What is new in symptomatic MS treatment: Part 3-bladder dysfunction].

Authors:  T Henze; W Feneberg; P Flachenecker; D Seidel; H Albrecht; M Starck; S G Meuth
Journal:  Nervenarzt       Date:  2018-02       Impact factor: 1.214

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.